In this Section |
259456 Correlates of Intent to Increase Sexual Risk-Taking After HPV VaccinationTuesday, October 30, 2012
: 5:10 PM - 5:30 PM
Background: Few studies have investigated women's intent to increase sexual risk-taking after completing the 3-dose HPV vaccine series. Methods: After receiving dose 1 of the HPV vaccine for free, 344 Appalachian women (ages 18-26) completed a brief survey. Results: Mean age was 22.0 years (SD=2.4). 45% of the women indicated intent to increase sexual risk-taking. Being married (P=.87), having children (P=.37), and age (P=.31) were not associated with this intent. Intent was higher among those who “worried” about cervical cancer compared to who did not (51.6% vs. 33.3%; P=.01). Among women with friends or family with cervical cancer, 43.0% indicated this intent compared with 28.6% of women without diagnosed friends or family (P=.019). Bisexual women indicated this intent more so than heterosexual women (69.7% vs. 21.6%; P<.0001). Using a 4-item fatalism measure (after performing a median split to dichotomize a skewed distribution), 54% of those scoring high in fatalism stated the intent compared to 36% scoring lower on this measure (P<.001). Women with a history of abnormal Pap results were less likely to indicate this intent compared to those never having this experience (33.1% vs. 53.9%; P<.0001). In a multiple logistic regression model, only two of the five associations retained significance: being bisexual (AOR=5.15, 95% CI=2.00-13.30) and cervical cancer worry (AOR=3.25; 95% CI=1.40-7.83). Conclusion: Intent to increase sexual risk-taking after HPV vaccination was high and did not vary by marital status, having children, or age. Intent was particularly high for bisexual women and those indicating worry about cervical cancer.
Learning Areas:
Public health or related researchSocial and behavioral sciences Learning Objectives: Keywords: Cervical Cancer, Sexual Risk Behavior
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I serve as Deputy Director of the CDC-funded, University of Kentucky Rural Cancer Prevention Center. I helped design, implement, and evaluate the HPV vaccination project. I have been practicing in cancer control for over 10 years. I also teach graduate health behavior and rural health courses. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4417.0: HPV, other STIs, and public health
|